Picture of Induction Healthcare logo

INHC Induction Healthcare News Story

0.000.00%
gb flag iconLast trade - 00:00
TechnologySpeculativeMicro CapNeutral

REG - Induction Healthcare - Purchase of Shares by Directors

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211202:nRSB3910Ua&default-theme=true

RNS Number : 3910U  Induction Healthcare Group PLC   02 December 2021

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Purchase of Shares by Directors

 

Induction Healthcare (AIM: INHC), a leading flexible care company, announces
the following Director purchases of, in aggregate, 130,000 ordinary share in
the Company:

 

Andy Williams, Non-Executive Director, purchased 100,000 Ordinary Shares at a
price of 48 pence per ordinary share. As a result of this transaction, Andy
Williams' total shareholding in the Company comprises 519,495 Ordinary Shares,
representing approximately 0.56 per cent. of the Company's issued share
capital.

 

Hugo Stephenson, Group Executive Director, purchased 30,000 Ordinary Shares at
a price of 48 pence per ordinary share. As a result of this transaction, Hugo
Stephenson's total shareholding in the Company comprises 2,126,273 Ordinary
Shares, representing approximately 2.31 per cent. of the Company's issued
share capital.  This excludes the 7,152,600 Ordinary Shares which are held by
Blue Muse Investments Pty Ltd, as trustee of The Blue Muse Trust (a trust
which is controlled by Hugo Stephenson's mother and of which close relatives
including his children and friends of Hugo Stephenson are beneficiaries).

 

 

ENQUIRIES

 

 Induction                                              Via Walbrook PR Ltd: induction@walbrookpr.com

                                                      (mailto:induction@walbrookpr.com)
 James Balmain, Chief Executive Officer

 Singer Capital Markets (Nominated Adviser and Broker)  +44 (0) 20 7496 3000
 Philip Davies / Kailey Aliyar

 Walbrook PR Ltd                                        induction@walbrookpr.com
 Paul McManus / Alice Woodings / Megan Boxall           Mob: +44(0)7980 541 893 / +44 (0)7407 804 654 / +44 (0)7788 151 967

 

About Induction -  www.inductionhealthcare.com
(http://www.inductionhealthcare.com)

 

Induction (AIM: INHC) is a leading flexible care platform driving digital
transformation of healthcare systems worldwide. Induction solutions enhance
the investments hospitals have made and lay the foundation for their future.
Our products can enable information sharing between busy doctors, alleviate
operational burdens on hospitals or put patients in better control of their
care, all while ensuring the highest standards of clinical safety and
information security. We unchain staff and patients from the limitations of
paper-based and desktop systems, creating substantial time and cost
efficiencies.

 

More than 225,000 hospital doctors across multiple territories, including the
UK, Ireland, Australia and South Africa, as well as a rapidly growing number
of more than 300,000 UK patients, choose Induction solutions.

 

Induction Switch is the number one healthcare collaboration app in the UK,
used by the majority of hospital doctors within the NHS. The app helps to
increase productivity and enhance communication by securely sharing phone
numbers and bleeps, bookmarks, documents and messages in a clinical setting.

 

Induction Guidance provides medical organisations, including most hospital
trusts within the NHS, with the ability to collaboratively create, edit, and
publish their own local medical guidelines in a secure and locally
administrated environment. This increases knowledge of, and adherence to,
guidance.

 

Induction Zesty is a market-leading digital platform for patients visiting
hospitals. The platform allows patients to book and access their appointments,
read their clinical letters, store a copy of their clinical record and provide
data to their care teams remotely. It is not just a compelling patient
experience, but also delivers significant cost benefits to hospitals.

 

Induction Attend Anywhere is the UK market leader in secondary care video
consultations. It helps hospitals, health systems and other customers offer
video consultations to patients and service users as a normal part of
day-to-day clinical activity. Our vision is for video consultations to improve
lives and help address social, access, equity and sustainability challenges by
allowing healthcare providers to determine how and when they see a patient
based on each individual case: in-person, via video or on the telephone.

 

Induction HealthStream is a proprietary data integration platform that reads
and writes patient demographic, appointment and clinical record data between a
growing number of hospital EHR systems and the Induction platforms. This
connectivity between stakeholders and legacy IT systems adds substantial value
to pre-existing health IT investment and allows large-scale adoption of
Induction app-based services.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHUUAURANUURAA

Recent news on Induction Healthcare

See all news